Severe Psychiatric Problems in Right Hepatic Lobe Donors for Living Donor Liver Transplantation by Trotter, James F. et al.
Severe Psychiatric Problems in Right Hepatic Lobe Donors for
Living Donor Liver Transplantation
James F. Trotter1,9, Margaret M. Hill-Callahan2, Brenda W. Gillespie3, Carrie A. Nielsen4,
Sammy Saab5, Roshan Shrestha6, Michael M. Talamantes7, Robert M. Weinrieb8, and the
A2ALL Study Group
1Department of Surgery, University of Colorado, Denver, CO
2Department of Surgery, University of Michigan, Ann Arbor, MI
3Department of Biostatistics, University of Michigan, Ann Arbor, MI
4Department of Hepatology, University of North Carolina, Chapel Hill, NC
5Department of Medicine, University of California Los Angeles, Los Angeles, CA
6Department of Transplant Services, Piedmont Hospital, Atlanta, GA
7Department of Transplant Surgery, University of Colorado, Denver, CO
8Department of Psychiatry, University of Pennsylvania, Philadelphia, PA
Abstract
Background—The morbidity and mortality from donation of a right hepatic lobe for living
donor liver transplantation (LDLT) is an important issue for this procedure. We report the
prevalence of severe psychiatric postoperative complications from the Adult-to-Adult Living
Donor Liver Transplantation Cohort study (A2ALL), which was established to define the risks and
benefits of LDLT for donors and recipients.
Methods—Severe psychiatric complications were evaluated in all donors from the A2ALL study
who were evaluated between 1998 and February 2003.
Results—Of the 392 donors, 16 (4.1%) had one or multiple psychiatric complications, including
three severe psychiatric complications (suicide, accidental drug overdose, and suicide attempt).
Conclusions—Despite extensive preoperative screening, some donors experience severe
psychiatric complications, including suicide, after liver donation. Psychiatric assessment and
monitoring of liver donors may help to understand and prevent such tragic events.
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The spectrum of complications experienced by donors in living donor liver transplantation
(LDLT) has been described in a number of publications. As many as 67% of donors develop
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postoperative complications (1–4). Most of the other reported problems are typical for a
major abdominal surgery, including wound infection, blood transfusion, and reoperation.
However, there are very few data describing psychiatric complications in living liver donors,
in part, because of their infrequent occurrence. In addition, almost all of the data on donor
complications are derived from either single-center reports or transplant center survey data,
neither of which is particularly well-suited to examine donor psychiatric problems. Single-
center reports have the advantage of complete data collection but include small numbers of
patients. As a result, uncommon events, such as psychiatric complications, may be missed or
underappreciated. Surveys of LDLT centers include more patients but have the
disadvantages of retrospective data collection, absence of consensus definitions of
complications between centers and, in some cases, inadequate donor follow-up. All of these
circumstances could lead to underreporting of complications. The Adult-to-Adult Living
Donor Liver Transplantation Cohort Study (A2ALL) is uniquely designed to study
uncommon complications, such as psychiatric events, because of (1) the large number of
donors studied, (2) consensus definitions of complications at all centers, and (3) dedicated
research coordinators to ensure completeness of data collection. In this report, we describe
the prevalence and type of severe psychiatric complications in the 392 donors enrolled in the
A2ALL study.
METHODS
A2ALL includes nine U.S. liver transplantation centers (5). Between January 1, 1998, and
February 28, 2003, these centers evaluated 1101 donor candidates for 819 potential LDLT
recipients. Among those donor candidates, 392 had a completed donation. Using
standardized forms, data were retrospectively collected on all donor and recipient
candidates. The study was approved by the Institutional Review Boards and Privacy Boards
of the Data Coordinating Center (DCC) and each of the nine participating transplant centers.
Psychiatric evaluations were performed at the discretion of each center. All donor candidates
in the cohort did not undergo psychiatric evaluation before donation.
All postdonation complications were tracked. The Clavien Classification system (6) was
used to define and grade the severity of complications. The Clavien system defines a
complication as “any deviation from the normal postoperative course.” The complication’s
severity is established using a system that includes interventions/medications that are
required to treat or resolve the event, and outcomes of the event. Complications are graded
from 1 (least severe) to 4 (most severe). All reported information on psychiatric
complications and deaths of donors was reviewed. Patients with any psychiatric
complication were identified, and detailed questionnaires were completed using in-depth
chart review for patients with severe psychiatric complications. (Psychiatric complications
that were considered life-threatening, i.e., Grade 3, or caused death, i.e., Grade 4, were
considered “severe”). Descriptive statistics included proportion, median, and range as
appropriate. All analyses were performed using SAS version 9.1 (SAS Institute, Cary, NC).
RESULTS
Of the 392 donors, 16 (4.1%) had one or multiple psychiatric complications (12 depression,
2 anxiety, 1 bipolar disorder, 1 accidental overdose, 1 insomnia, 1 crying episodes, 1
worsening of obsessive-compulsive disorder, 2 substance abuse), including 3 severe
psychiatric complications (suicide, accidental drug overdose, and suicide attempt). The
median postoperative follow-up was 6 months (range, 3 days to 5.6 years). The 3 severe
psychiatric complications are described herein.
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Case 1 was a 50-year-old man who donated to his niece. He was under psychiatric care
before and after donation for bipolar disorder and treated with clonazepam. He was deemed
to be emotionally stable and proceeded to liver donation. His postoperative course was
complicated by a middle hepatic vein thrombosis, abdominal discomfort, and fatigue. He
died of a self-inflicted gunshot wound to the head 22 months after donation. Case 2 was a
35-year-old man who donated to his brother. Postoperatively, he developed a pleural
effusion, ileus, and mild urinary retention. He had no psychiatric history but had counseling
before donation related to a divorce. He died of a drug overdose 23 months after donation.
Case 3 was a 23-year-old man who donated to his father, with no posthepatectomy
complications. Nine months after donation following a break-up with his significant other,
he required psychiatric admission twice within 2 months after attempting suicide by slashing
his wrists. The recipients of all three donors had minimal postoperative complications and
were alive and well at the time of the donor suicide or suicide attempt.
DISCUSSION
The current understanding of the psychiatric problems experienced by living liver donors is
very limited. There are only a few published reports regarding the frequency and nature of
psychiatric complications in this group of patients. Walter et al. (7) assessed psychosocial
stress in 46 donors 6 months after donation. They reported that 11% of the donors had an
“enhanced perception of stress.” Goldman reported outcomes in 20 living liver donors to
pediatric recipients and found two marital dissolutions and one adjustment disorder in this
cohort (8). In Japan, psychiatric problems were described in 31 LDLT donors in whom
major depressive disorder occurred in three patients (10%) (9). There are reports of
depression and completed suicides in cases of living donor kidney transplantation. Johnson
et al. (10) analyzed outcomes in 524 living kidney donors in which 23% of respondents
experienced self-reported depression after surgery and 15% reported depression within one
month before the survey. In addition, three suicides have been reported in living kidney
donors (11, 12).
The major focus of complications in living liver donors has been directed toward surgical
complications occurring in the immediate postoperative period. However, psychiatric
complications may occur long after surgery. During this phase of postoperative recovery,
assessment of donors at most centers may be very limited or nonexistent. Beavers et al. (13)
reported practice patterns of long-term follow-up in LDLT donors in the United States. At 1
year after the donor surgery, only 25% of centers had scheduled clinic visits with the donor,
only 14% required blood chemistries, and only one program administered a follow-up
survey of the donors. Without careful donor monitoring during the late phase of
postoperative recovery, physicians at LDLT centers are unlikely to recognize important
psychiatric problems in their donors. Consequently, transplant physicians are advised to
consider long-term follow-up of their donors. By doing so, the full extent of post-
transplantation psychiatric problems could be identified, and those individuals could be
treated. In addition, risk factors for psychiatric or psychological complications may be
identified so that methods to reduce or avoid these problems could be implemented in future
donors.
Our data do not explain whether living liver donors are inherently more prone to psychiatric
problems or whether the stress of the evaluation and hepatectomy may increase this risk.
The donor cohort is likely more physically and psychologically healthy than the general
population because of the careful screening and evaluation of donor candidates. Potential
donors with significant psychiatric problems identified during the evaluation routinely are
rejected for donation. Many centers would have rejected donor 1 as a candidate based on the
previous history of psychiatric problems. Furthermore, many centers include a psychiatric
Trotter et al. Page 3













assessment of each donor during the evaluation. In addition, previous studies have shown
that the donors scored as high or significantly higher than the general population in objective
measures of quality-of-life (SF-36) (14). Finally, Surman et al. (15) have suggested that
donors may be so driven to donate that they may attempt to conceal underlying
psychopathology. Despite these relevant factors, which would suggest a higher level of
mental health in liver donors, some patients experienced severe psychiatric complications,
including suicide after donation. We cannot directly attribute the donor surgery to the
suicides, attempted suicides, or other less-severe psychiatric complications noted in the
retrospective study, since these problems may have existed to some degree prior to donation.
The national suicide rate is approximately 1/10,000. The relatively small number of patients
in our cohort makes estimates of suicide rate problematic. However, two successful suicides
in this small cohort are two orders of magnitude higher than the national rate, and is cause
for concern.
In summary, we have shown that severe psychiatric complications occur in a small segment
of living donors after donor surgery. Careful preoperative assessment and postoperative
monitoring of these patients may help to understand and prevent such tragic events. Our
study also highlights the need for continual clinical follow-up for living liver donors. It is
our hope that future data coming from the A2ALL prospective study will continue to shed
light on this issue and perhaps assist clinicians in identifying factors that may place
prospective donors at increased risk for future psychological complications.
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